Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis

Martina Rami, Raquel Guillamat-Prats, Petteri Rinne, Melanie Salvermoser, Larisa Ring, Mariaelvy Bianchini, Xavier Blanchet, Remco T. A. Megens, Yvonne Doring, Barbara Walzog, Oliver Soehnlein, Christian Weber, Alexander Faussner, Sabine Steffens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1007-1019
Number of pages13
JournalArteriosclerosis Thrombosis and Vascular Biology
Volume38
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • antidepressive agents
  • atherosclerosis
  • fluoxetine
  • integrins
  • serotonin
  • MYELOID CELL RECRUITMENT
  • INTEGRIN ALPHA-IIB-BETA-3
  • CARDIOVASCULAR-DISEASE
  • PERIPHERAL SEROTONIN
  • APOLIPOPROTEIN-E
  • DEPRESSION
  • MICE
  • RISK
  • ACTIVATION
  • DEFICIENT

Cite this